New scope could revolutionize surgery before birth

NCT ID NCT06281730

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests new, improved fetoscopes—tiny telescopes used to perform surgery on a baby while still in the womb. Researchers at Mayo Clinic will enroll 100 pregnant women to see if the devices are safe and work well. The goal is to improve outcomes for conditions like twin-to-twin transfusion syndrome, but the scopes are not yet FDA-approved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Karl Storz New Generation Fetoscope (a thin telescope-like device used to perform surgery on a fetus inside the womb)
What this could lead to
If successful, this could lead to safer and more effective fetal surgeries for conditions like twin-to-twin transfusion syndrome.
What could go wrong
This is an early feasibility study, not a large trial. The devices are not yet FDA-approved, and there are risks to both mother and baby, including preterm labor or surgical complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IN UTERO PROCEDURE AFFECTING FETUS OR NEWBORN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Minnesota

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.